Literature DB >> 23684698

Potential role of human-specific genes, human-specific microRNAs and human-specific non-coding regulatory RNAs in the pathogenesis of systemic sclerosis and Sjögren's syndrome.

Sergio A Jimenez1, Sonsoles Piera-Velazquez.   

Abstract

The etiology and pathogenesis of human autoimmune diseases remain unknown despite intensive investigations. Although remarkable progress has been accomplished through genome wide association studies in the identification of genetic factors that may predispose to their occurrence or modify their clinical presentation to date no specific gene abnormalities have been conclusively demonstrated to be responsible for these diseases. The completion of the human and chimpanzee genome sequencing has opened up novel opportunities to examine the possible contribution of human specific genes and other regulatory elements unique to the human genome, such as microRNAs and non-coding RNAs, towards the pathogenesis of a variety of human disorders. Thus, it is likely that these human specific genes and non-coding regulatory elements may be involved in the development or the pathogenesis of various disorders that do not occur in non-human primates including certain autoimmune diseases such as Systemic Sclerosis and Primary Sjögren's Syndrome. Here, we discuss recent evidence supporting the notion that human specific genes or human specific microRNA and other non-coding RNA regulatory elements unique to the human genome may participate in the development or in the pathogenesis of Systemic Sclerosis and Primary Sjögren's Syndrome.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune diseases; Human specific genes; MicroRNAs; Non-coding RNA; Sjögren's Syndrome; Systemic Sclerosis

Mesh:

Substances:

Year:  2013        PMID: 23684698      PMCID: PMC3771096          DOI: 10.1016/j.autrev.2013.04.004

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  105 in total

Review 1.  Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities.

Authors:  Swati Bhattacharyya; Jun Wei; John Varga
Journal:  Nat Rev Rheumatol       Date:  2011-10-25       Impact factor: 20.543

Review 2.  The widespread regulation of microRNA biogenesis, function and decay.

Authors:  Jacek Krol; Inga Loedige; Witold Filipowicz
Journal:  Nat Rev Genet       Date:  2010-07-27       Impact factor: 53.242

Review 3.  Emerging complexity of microRNA generation cascades.

Authors:  Hiroshi I Suzuki; Kohei Miyazono
Journal:  J Biochem       Date:  2010-09-27       Impact factor: 3.387

Review 4.  Molecular mechanisms of long noncoding RNAs.

Authors:  Kevin C Wang; Howard Y Chang
Journal:  Mol Cell       Date:  2011-09-16       Impact factor: 17.970

Review 5.  Biologic therapies in rheumatology: lessons learned, future directions.

Authors:  Vibeke Strand; Robert Kimberly; John D Isaacs
Journal:  Nat Rev Drug Discov       Date:  2007-01       Impact factor: 84.694

Review 6.  Brain evolution and uniqueness in the human genome.

Authors:  Jordan P Amadio; Christopher A Walsh
Journal:  Cell       Date:  2006-09-22       Impact factor: 41.582

Review 7.  Pathophysiology of translational regulation by microRNAs in multiple sclerosis.

Authors:  Andreas Junker
Journal:  FEBS Lett       Date:  2011-03-29       Impact factor: 4.124

8.  Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling.

Authors:  Daniel M Hornan; Stuart N Peirson; Alison J Hardcastle; Robert S Molday; Michael E Cheetham; Andrew R Webster
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-12       Impact factor: 4.799

9.  The context of gene expression regulation.

Authors:  Johan H Gibcus; Job Dekker
Journal:  F1000 Biol Rep       Date:  2012-04-02

10.  Human-specific loss of regulatory DNA and the evolution of human-specific traits.

Authors:  Cory Y McLean; Philip L Reno; Alex A Pollen; Abraham I Bassan; Terence D Capellini; Catherine Guenther; Vahan B Indjeian; Xinhong Lim; Douglas B Menke; Bruce T Schaar; Aaron M Wenger; Gill Bejerano; David M Kingsley
Journal:  Nature       Date:  2011-03-10       Impact factor: 49.962

View more
  19 in total

1.  Upregulation of long noncoding RNA TMEVPG1 enhances T helper type 1 cell response in patients with Sjögren syndrome.

Authors:  Juan Wang; Huiyong Peng; Jie Tian; Jie Ma; Xinyi Tang; Ke Rui; Xinyu Tian; Yungang Wang; Jianguo Chen; Liwei Lu; Huaxi Xu; Shengjun Wang
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 2.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 3.  Intravenous immunoglobulins (IVIG) in systemic sclerosis: a challenging yet promising future.

Authors:  Luca Cantarini; Donato Rigante; Antonio Vitale; Salvatore Napodano; Lazaros I Sakkas; Dimitrios P Bogdanos; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

4.  Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis.

Authors:  Chider Chen; Dandan Wang; Alireza Moshaverinia; Dawei Liu; Xiaoxing Kou; Wenjing Yu; Ruili Yang; Lingyun Sun; Songtao Shi
Journal:  Cell Res       Date:  2017-01-20       Impact factor: 25.617

Review 5.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

Review 6.  Autoimmunity in 2013.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

7.  Unique topics and issues in rheumatology and clinical immunology.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2014-08       Impact factor: 8.667

8.  Relationship of miRNA-146a to primary Sjögren's syndrome and to systemic lupus erythematosus: a meta-analysis.

Authors:  Hong-Yan Sun; An-Kun Lv; Hua Yao
Journal:  Rheumatol Int       Date:  2017-06-01       Impact factor: 2.631

Review 9.  Role of Micro RNAs in the Pathogenesis of Rheumatoid Arthritis: Novel Perspectives Based on Review of the Literature.

Authors:  Xiu-Min Chen; Qing-Chun Huang; Sheng-Li Yang; Yong-Liang Chu; Yu-Hong Yan; Ling Han; Yu Huang; Run-Yue Huang
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

Review 10.  MicroRNAs Regulating Signaling Pathways: Potential Biomarkers in Systemic Sclerosis.

Authors:  Yisha Li; Jing Huang; Muyao Guo; Xiaoxia Zuo
Journal:  Genomics Proteomics Bioinformatics       Date:  2015-09-11       Impact factor: 7.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.